Revenue (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2021

Dec. 31, 2020

TOI Parent Inc.

Summary of disaggregation of revenue

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2021		2020		2021		2020
Patient services
Capitated revenue	$	14,124,468	$	9,720,441	$	39,351,829	$	26,177,975
FFS revenue		18,842,933		19,943,443		53,023,939		60,807,538
Subtotal		32,967,401		29,663,884		92,375,768		86,985,513
Dispensary revenue		17,918,035		16,162,528		53,317,877		46,347,096
Clinical research trials & other revenue		1,389,522		1,423,032		5,004,889		5,216,372
Total	$	52,274,958	$	47,249,444	$	150,698,534	$	138,548,981

					Period from		Period from
					September 20,		January 1,
	Year Ended		Year Ended		2018 through		2018 through
	December 31,		December 31,		December 31,		September 19,
	2020		2019		2018		2018
					Successor		Predecessor
Patient services
Capitated revenue	$	37,381,005	$	31,229,328	$	8,947,525	$	20,560,867
FFS revenue		79,435,792		66,395,553		12,337,260		27,966,161
Subtotal		116,816,797		97,624,881		21,284,785		48,527,028
Dispensary revenue		63,889,875		49,953,992		13,201,609		26,757,955
Clinical research trials and other revenue		6,807,989		7,826,311		2,872,995		515,742
Total	$	187,514,661	$	155,405,184	$	37,359,389	$	75,800,725